In vivo evaluation of the highly soluble oral β-cyclodextrin- Sertraline supramolecular complexes

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 478-485

  Passos, Joel J ^a   De Sousa, Frederico B ^a   Mundim, Iram M ^b   Bonfim, Ricardo R ^b   Melo, Robson ^b   Viana, Alice F ^c   Stolz, Eveline D ^c   Borsoi, Milene ^c   Rates, Stela M K ^c   Sinisterra, Rubén D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Instituto de Ciências Farmacêuticas ICF   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cyclodextrin; Behavior test; Freeze dryer; In vivo experiments; Inclusion complex; Sertraline

Indexed keywords

BETA CYCLODEXTRIN; SERTRALINE;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; FOURIER TRANSFORMATION; FREEZE DRYING; IN VIVO STUDY; INFRARED SPECTROSCOPY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID STATE; SUPRAMOLECULAR CHEMISTRY; X RAY POWDER DIFFRACTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BETA-CYCLODEXTRINS; HINDLIMB SUSPENSION; MALE; MICE; MOTOR ACTIVITY; POWDER DIFFRACTION; SERTRALINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84865305896     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.061     Document Type: Article

References (33)

1. Allen, D.J.M.; Sysko, R.J.; 1993. Sertraline Polymorph, US Patent number 5,248,699.
2. D.T. Auguste, K. Furman, A. Wong, J. Fuller, S.P. Armes, T.J. Deming, and R. Langer Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes J. Control. Release 130 2008 266 274
3. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat. Rev. Neurosci. 7 2006 137 151
4. F. Caruso, A. Besmer, and M. Rossi The absolute configuration of sertraline (Zoloft) hydrochloride Acta Crystallogr. C: Cryst. Struct. Commun. 55 1999 1712 1714
5. J.M. Chan, L. Zhang, K.P. Yuet, G. Liao, J.-W. Rhee, R. Langer, and O.C. Farokhzad PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
6. J.F. Cryan, and A. Holmes The ascent of mouse: advances in modelling human depression and anxiety Nat. Rev. Drug Discov. 4 2005 775 790
7. M.E. Davis, and M.E. Brewster Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 2004 1023 1035
8. F.B. De Sousa, D.T. João, Guerreiro, Minglin Ma, G. Daniel, Anderson, L. Chester, Drum, D. Rubén, Sinisterra, and R. Langer Photo-response behavior of electrospun nanofibers based on spiropyran- cyclodextrin modified polymer J. Mater. Chem. 20 2010 9910 9917
9. F.B. De Sousa, A.C. Lima, Â.M.L. Denadai, C.P.A. Anconi, W.B. De Almeida, W.T.G. Novato, H.F. Dos Santos, C.L. Drum, R. Langer, and R.D. Sinisterraa Superstructure based on β-CD self-assembly induced by small guest molecule Phys. Chem. Chem. Phys. 14 2012 1934 1944
10. E.M.M. Del Valle Cyclodextrins and their uses: a review Process Biochem. 39 2004 1033 1046
11. C.M. Fernandes, M.T. Vieira, and F.J.B. Veiga Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur. J. Pharm. Biopharm. 15 2002 79 88
12. F. Giordano, C. Novak, and J.R. Moyano Thermal analysis of cyclodextrins and their inclusion compounds Thermochim. Acta 380 2001 123 151
13. A. Harada, R. Kobayashi, Y. Takashima, A. Hashidzume, and H. Yamaguchi Macroscopic self-assembly through molecular recognition Nat. Chem. 3 2011 34 37
14. C. Hiemke, and S. Hartter Pharmacokinetics of selective serotonin reuptake inhibitors Pharmacol. Ther. 85 2000 11 28
15. F. Hirayama, and K. Uekama Cyclodextrin-based controlled drug release system Adv. Drug Deliv. Rev. 36 1999 125 141
16. B.M. Johnson, P.-T.L. Chang, and G.B. Harry Sertraline Hydrochloride Analytical Profiles of Drug Substances and Excipients 1996 Academic Press pp. 443-486
17. L.S. Koester, C.R. Xavier, P. Mayorga, and V.L. Bassani Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets Eur. J. Pharm. Biopharm. 55 2003 85 91
18. A. Latrofa, G. Trapani, M. Franco, M. Serra, M. Muggironi, F.P. Fanizzi, A. Cutrignelli, and G. Liso Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice Eur. J. Pharm. Biopharm. 52 2001 65 73
19. I. Lula, F.B. De Sousa, Â.M.L. Denadai, D. Ianzer, A.C.M. Camargo, R.A.S. Santos, and R.D. Sinisterra Study of the BPP7a peptide and its β-cyclodextrin complex: physicochemical characterization and complete sequence specific NMR assignments J. Braz. Chem. Soc. 22 2011 1765 1773
20. W.R. Malfara, C. Bertucci, M.E. Costa Queiroz, S.A. Dreossi Carvalho, M. Pires Bianchi, d.L. Cesarino, E.J. Crippa, and J.A.R.H. Costa Queiroz Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants J. Pharm. Biomed. Anal. 44 2007 955 962
21. F.D. Marques, A.J. Ferreira, R.D.M. Sinisterra, B.A. Jacoby, F.B. Sousa, M.V. Caliari, G.A.B. Silva, M.B. Melo, A.P. Nadu, L.E. Souza, M.C.C. Irigoyen, A.P. Almeida, and R.A.S. Santos An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats Hypertension 57 2011 477 483
22. 13C NMR studies on conformational polymorphism in sertraline hydrochloride, an antidepressant drug Magn. Reson. Chem. 40 2002 723 728
23. C.D. Nunes, P.D. Vaz, A.C. Fernandes, P. Ferreira, C.C. Romão, and M.J. Calhorda Loading and delivery of sertraline using inorganic micro and mesoporous materials Eur. J. Pharm. Biopharm. 66 2007 357 365
24. J.J. Passos, F.B. De Sousa, I.S. Lula, E.A. Barreto, J.F. Lopes, W.B. De Almeida, and R.D. Sinisterra Multi-equilibrium system based on sertraline and β-cyclodextrin supramolecular complex in aqueous solution Int. J. Pharm. 421 2011 24 33
25. B.A. Rezende, S.F. Cortes, F.B. De Sousa, I.S. Lula, M. Schmitt, R.D. Sinisterra, and V.S. Lemos Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein Int. J. Pharm. 367 2009 133 139
26. S. Sagdinc, F. Kandemirli, and S.H. Bayari Ab initio and density functional computations of the vibrational spectrum, molecular geometry and some molecular properties of the antidepressant drug sertraline (Zoloft) hydrochloride Spectrochim. Acta A: Mol. Biomol. Spectrosc. 66 2007 405 412
27. R. Speyer Thermal Analysis of Materials 1994 Marcel Dekker, Inc. New York
28. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test - a new method for screening antidepressants in mice Psychopharmacology (Berl.) 85 1985 367 370
29. S.C. Sutton, L.A. Evans, J.H. Fortner, J.M. McCarthy, and K. Sweeney Dog colonoscopy model for predicting human colon absorption Pharm. Res. 23 2006 1554 1563
30. J. Szejtli Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1998 1743 1754
31. K. Takács-Novák, K. Tihanyi, B. Noszál, and K. Deák Physico-chemical profiling of antidepressive sertraline: solubility, ionization, lipophilicity Med. Chem. 2 2006 385 389
32. T. Tokumura, A. Muraoka, and Y. Machida Improvement of oral bioavailability of flurbiprofen from flurbiprofen/β-cyclodextrin inclusion complex by action of cinnarizine Eur. J. Pharm. Biopharm. 73 2009 202 204
33. M.A. Zayed, M.F. Hawash, M.A. Fahmey, and A.A. Ei-Habeeb Structure investigation of sertraline drug and its iodine product using mass spectrometry, thermal analyses and MO-calculations Spectrochim. Acta A: Mol. Biomol. Spectrosc. 68 2007 970 978